Amussen Hunsaker Associates LLC Crispr Therapeutics Ag Transaction History
Amussen Hunsaker Associates LLC
- $776 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
488Shares Held
64.1MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$380 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$370 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$162 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$118 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$116 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.31B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....